Реваскуляризация миокарда при многососудистом атеросклеротическом поражении коронарного русла


Полный текст:

PDF


Аннотация


Обзор посвящен актуальной проблеме коронарной хирургии — реваскуляризации при многососудистом поражении. Рассмотрены результаты ретроспективных и проспективных исследований эффективности и безопасности различных видов коронарной хирургии. Проанализированы данные современной литературы относительно объема оперативного вмешательства, возможности ликвидации и профилактики рестеноза в просвете стента.

Поступила в редакцию 11 июля 2016 г. Принята к печати 31 августа 2016 г.

Финансирование
Исследование не имело спонсорской поддержки.
Конфликт интересов
Авторы заявляют об отсутствии конфликта интересов.
Благодарности
Авторы благодарят сотрудников кафедры кардиологии медицинского института Сургутского государственного университета и коллектив бюджетного учреждения Ханты-Мансийского автономного округа — Югры Окружного кардиологического диспансера за помощь в подготовке статьи.


Л. С. Калугина
Окружной кардиологический диспансер «Центр диагностики и сердечно-сосудистой хирургии», 628400, Ханты-Мансийский автономный округ — Югра (Тюменская область), Сургут, Российская Федерация; Сургутский государственный университет, 628412, Ханты-Мансийский автономный округ — Югра (Тюменская область), Российская Федерация

Для корреспонденции: Калугина Лидия Сергеевна, disonto@mail.ru 

Вклад автора: концепция и дизайн обзора, написание текста, внесение изменений в текст

И. А. Урванцева
Окружной кардиологический диспансер «Центр диагностики и сердечно-сосудистой хирургии», 628400, Ханты-Мансийский автономный округ — Югра (Тюменская область), Сургут, Российская Федерация; Сургутский государственный университет, 628412, Ханты-Мансийский автономный округ — Югра (Тюменская область), Российская Федерация

Вклад автора: контроль за написанием статьи, структурирование и редактирование обзора

Литература


     Список литературы

    1. Danchin N., Angioi M., Rodriguez R. Angioplasty in chronic coronary occlusion // Arch mal Coeur Vaiss. 1999. Vol. 99 (suppl. 11). P. 1657–1660.

    2. Meier B., Luethy P., Finci L., Steffenino G.D., Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals // Circulation. 2008. Vol. 75. No. 5. P. 906–913.

    3. Safley D.M., House J.A., Marso S.P., Grantham J.A., Rutherford B.D. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel // JACC Cardiovasc. Interv. 2008. Vol. 1. No. 3. P. 295–302. Article

    4. Бабунашвили А.М., Иванов В.А. Хронические окклюзии коронарных артерий: анатомия, патофизиология, эндоваскулярное лечение. М: АСВ, 2012. 90 c.

    5. Prasad A., Rihal C.S., Lennon R.J., Wiste H.J., Singh M., Holmes D.R. Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic // J. Am. Coll. Cardiol. 2007. Vol. 49. No. 15. P. 1611–1618.

    6. King S.B. 3rd, Kosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) // J. Am. Coll. Cardiol. 2000. Vol. 35. No. 5. P. 1116–1121.

    7. Hlatky M.A., Rogers WJ, Johnstone I., Boothroyd D., Brooks M.M., Pitt B., Reeder G., Ryan T., Smith H., Whitlow P., Wiens R., Mark D.B., Rosen A.D., Detre K., Frye R.L., for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery // N. Engl. J. Med. 1997. Vol. 336. No. 2. P. 92–99. Article

    8. Detre K.M., Lombardero M.S., Brooks M.M., Hardison R.M., Holubkov R., Sopko G., Frye R.L., Chaitman B.R. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators // N. Engl. J. Med. 2000. Vol. 342. No. 14. P. 989–997. Article

    9. Booth J., Clayton T., Pepper J., Nugara F., Flather M., Sigwart U., Stables R.H., SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) // Circulation. 2008. Vol. 118. No. 4. P. 381–388. Article

    10. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Ståhle E., Feldman T.E., van den Brand M., Bass E.J., Van Dyck N., Leadley K., Dawkins K.D., Mohr F.W.; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease // N. Engl. J. Med. 2009. Vol. 360. No. 10. P. 961–972. Article

    11. Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Ståhle E., Colombo A., Mack M.J., Holmes D.R. Jr., Morel M.A., Van Dyck N., Houle V.M., Dawkins K.D., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial // Lancet. 2013. Vol. 381. No. 9867. P. 629–638. Article

    12. Hueb W., Lopes N., Gersh B.J., Soares P.R., Ribeiro E.E., Pereira A.C., Favarato D., Rocha A.S., Hueb A.C., Ramires J.A. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease // Circulation. 2010. Vol. 122. No. 10. P. 949–957. Article

    13. Takagi H., Yamamoto H., Iwata K., Goto S.N., Umemoto T.; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Drug-eluting stents increase late mortality compared with coronary artery bypass grafting in triple-vessel disease: a meta-analysis of randomized controlled and risk-adjusted observational studies // Int. J. Cardiol. 2012. Vol. 159. No. 3. P. 230–233. Article

    14. Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization // Eur. Heart J. 2010. Vol. 31. No. 20. P. 2501–2555. Article

    15. Hillis L.D., Smith P.K., Anderson J.L. et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons // J. Am. Coll. Cardiol. 2011. Vol. 58. No. 24. P. e123–210. Article

    16. Coronary Revascularization Writing Group, Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography // J. Thorac. Cardiovasc. Surg. 2012. Vol. 143. No. 4. P. 780–803. Article

    17. Corpus R.A., House J.A., Marso S.P., Grantham J.A., Huber K.C. Jr., Laster S.B., Johnson W.L., Daniels W.C., Barth C.W., Giorgi L.V., Rutherford B.D. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction // Am. Heart J. 2004. Vol. 148. No. 3. P. 493–500. Article

    18. Meliga E., Fiorina C., Valgimigli M., Belli R., Gagnor A., Sheiban I., Resmini C., Tizzani E., Aranzulla T., Scrocca I., DE Benedictis M., Conte M.R. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease // J. Interv. Cardiol. 2011. Vol. 24. No. 6. P. 535–541. Article

    19. Vlaar P.J., Mahmoud K.D., Holmes D.R. Jr., van Valkenhoef G., Hillege H.L., van der Horst I.C., Zijlstra F., de Smet B.J. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis // J. Am. Coll. Cardiol. 2011. Vol. 58. No. 7. P. 692–703. Article

    20. Politi L., Sgura F., Rossi R., Monopoli D., Guerri E., Leuzzi C., Bursi F., Sangiorgi G.M., Modena M.G. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up // Heart. 2010. Vol. 96. No. 9. P. 662–667. Article

    21. Hannan E.L., Samadashvili Z., Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease // JACC Cardiovasc. Interv. 2010. Vol. 3. No. 1. P. 22–31. Article

    22. Bosch X., Marrugat J., Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes // Cochrane Database Syst. Rev. 2013. (11): CD002130. Article

    23. Xu X., Zhang W., Zhou Y., Zhao Y., Liu Y., Shi D., Zhou Z., Ma H., Wang Z., Yu M., Ma Q., Gao F., Shen H., Zhang J. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up // Clin. Drug Investig. 2014. Vol. 34. No. 4. P. 251–8. Article

    24. Wohrle J., Krause B.J., Nusser T., Kochs M., Hoher M. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy // Cardiovasc. Revasc. Med. 2006. Vol. 7. No. 1. P. 2–6. Article

    25. Eisenberg M.J., Konnyu K.J. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis // Am. J. Cardiol. 2006. Vol. 98. No. 3. P. 375–382. Article

    26. Akin I., Schneider H., Ince H., Kische S., Rehders T.C., Chatterjee T., Nienaber C.A. Second- and third-generation drug-eluting coronary stents: progress and safety // Herz. 2011.  Vol. 36. No. 3. P. 190–196. Article

    27. Калугина Л.С., Урванцева И.А. Реваскуляризация миокарда при многососудистом поражении коронарного русла в сочетании с хронической окклюзией. Выбор тактики // Атеросклероз. 2015. Т. 11. № 4. С. 74–82.

    References

    1. Danchin N, Angioi M, Rodriguez R. Angioplasty in chronic coronary occlusion. Arch mal Coeur Vaiss. 1999;99(suppl. 11):1657-1660.

    2. Meier B, Luethy P, Finci L, Steffenino GD, Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation. 2008;75(5):906-913.

    3. Safley DM, House JA, Marso SP, Grantham JA, Rutherford BD. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv. 2008;1(3):295-302. Article

    4. Babunashvili AM, Ivanov VA. Hronicheskie okklyuzii koronarnyh arterij: anatomiya, patofi ziologiya, ehndovaskulyarnoe lechenie. Moscow, ASV Publ., 2012. 90 p. (In Russ.).

    5. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol. 2007;49(15):1611-1618.

    6. King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35(5):1116-1121.

    7. Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB, Rosen AD, Detre K, Frye RL, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 1997;336(2):92-99. Article

    8. Detre KM, Lombardero MS, Brooks M.M., Hardison R.M., Holubkov R., Sopko G., Frye R.L., Chaitman B.R. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med. 2000;342(14):989-997. Article

    9. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, Stables RH, SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008;118(4):381-388. Article

    10. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972. Article

    11. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-638. Article

    12. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122(10):949-957. Article

    13. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Drug-eluting stents increase late mortality compared with coronary artery bypass grafting in triple-vessel disease: a meta-analysis of randomized controlled and risk-adjusted observational studies. Int J Cardiol. 2012;159(3):230-233. Article

    14. Wijns W, Kolh P, Danchin N. et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555. Article

    15. Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(24):e123-210. Article

    16. Coronary Revascularization Writing Group, Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg. 2012;143(4):780-803. Article

    17. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J. 2004;148(3):493-500. Article

    18. Meliga E, Fiorina C, Valgimigli M, Belli R, Gagnor A, Sheiban I, Resmini C, Tizzani E, Aranzulla T, Scrocca I, DE Benedictis M, Conte MR. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease. J Interv Cardiol. 2011;24(6):535-541. Article

    19. Vlaar PJ, Mahmoud KD, Holmes DR Jr, van Valkenhoef G, Hillege HL, van der Horst IC, Zijlstra F, de Smet BJ. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011;58(7):692-703. Article

    20. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM, Modena MG. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010;96(9):662-667. Article

    21. Hannan EL, Samadashvili Z, Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010;3(1):22-31. Article

    22. Bosch X., Marrugat J., Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database Syst Rev. 2013. (11): CD002130. Article

    23. Xu X, Zhang W, Zhou Y, Zhao Y, Liu Y, Shi D, Zhou Z, Ma H, Wang Z, Yu M, Ma Q, Gao F, Shen H, Zhang J. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up. Clin Drug Investig. 2014;34(4):251-8. Article

    24. Wohrle J, Krause BJ, Nusser T, Kochs M, Hoher M. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy. Cardiovasc Revasc Med. 2006;7(1):2-6. Article

    25. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol. 2006;98(3):375-382. Article

    26. Akin I, Schneider H, Ince H, Kische S, Rehders TC, Chatterjee T, Nienaber CA. Second- and third-generation drug-eluting coronary stents: progress and safety. Herz. 2011;36(3):190-196. Article

    27. Kalugina LS, Urvantseva IA. Myocardial revascularization in multivessel coronary lesions in conjunction with chronic occlusion. Choosing tactics. Ateroskleroz. 2015;11(4):74-82. (In Russ.).


Калугина Л. С., Урванцева И. А. Реваскуляризация миокарда при многососудистом атеросклеротическом поражении коронарного русла. Патология кровообращения и кардиохирургия. 2016;20(3):14-19. http://dx.doi.org/10.21688/1681-3472-2016-3-14-19


DOI: http://dx.doi.org/10.21688/1681-3472-2016-3-14-19

Ссылки

  • На текущий момент ссылки отсутствуют.


Лицензия Creative Commons
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.